- Home
- TNON vs TULP Comparison
TNON vs TULP Comparison
Compare TNON & TULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.79
N/A
Current Price
$3.91
Company Overview
Basic Information| Metric | TNON | TULP |
|---|---|---|
| Founded | 2012 | 1990 |
| Country | United States | United States |
| Employees | 27 | N/A |
| Industry | Medical Specialities | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4M | 8.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TNON | TULP |
|---|---|---|
| Price | $0.79 | $3.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 152.5K | 3.3K |
| Earning Date | 03-19-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.56 | N/A |
| Revenue Next Year | $71.06 | N/A |
| P/E Ratio | ★ N/A | $3.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $3.63 |
| 52 Week High | $5.85 | $4.79 |
Technical Indicators
Market Signals| Indicator | TNON | TULP |
|---|---|---|
| Relative Strength Index (RSI) | 48.15 | 41.48 |
| Support Level | $0.72 | $3.79 |
| Resistance Level | $0.89 | $4.15 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 38.28 | 16.65 |
Price Performance
Historical Comparison TNON
TULP
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.